Recent studies have also shown that duplication of the VPAC2 gene, and the resulting higher than normal VPAC2 signaling in patients confer a significant risk to schizophrenia (Beri et al., 2012; Levinson et al., 2011; Vacic et al., 2011). The gene discussed is VIPR2; the disease is schizophrenia.